Jianfeng Cai

Tampa, FL, United States of America

Jianfeng Cai

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: **Innovations and Contributions of Jianfeng Cai in Therapeutic Peptide Research**

Introduction

Jianfeng Cai, located in Tampa, FL, has made significant strides in the field of therapeutic peptide research, holding a remarkable total of 26 patents to his name. His work primarily focuses on developing innovative compounds that aim to address critical medical challenges, particularly in the area of cancer treatment and neurodegenerative diseases.

Latest Patents

Among his latest innovations, Cai has developed a peptidomimetic-based antibody surrogate for HER2. This patent discloses cyclic γ-amino acid peptide compounds and methods for using these compounds in the treatment of cell proliferative disorders, such as cancer. Additionally, it includes methods for detecting HER2 with these compounds and kits containing these innovations.

Another noteworthy patent by Cai relates to novel sulfono-γ-AA peptides. This patent discusses compositions, pharmaceutical formulations, and methods associated with these peptides that exhibit minimal toxicity. These innovative peptides have shown potential in repairing neuronal damage, inhibiting Amyloid beta aggregation, and promoting cellular growth and viability, which are crucial for progressing therapeutic treatments for neurodegenerative conditions.

Career Highlights

Cai's contributions to the scientific community have been backed by his tenure at reputable institutions, including the University of South Florida and H. Lee Moffitt Cancer Center and Research Institute. His research and innovations have positioned him as a key figure in peptide therapy.

Collaborations

Throughout his career, Jianfeng Cai has collaborated with other distinguished scientists, including Chuanhai Cao and Haifan Wu. These partnerships have fostered a shared vision of advancing peptide-based therapies and have significantly enhanced the impact of their collective research endeavors.

Conclusion

Jianfeng Cai's extensive patent portfolio and his contributions in therapeutic peptide research underscore his role as a leading innovator in the field. His latest developments offer promising avenues for treatment and detection methodologies that could revolutionize approaches to both cancer and neurodegenerative diseases. With his continued efforts and collaborations, Cai is set to make further impactful contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…